Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.54

+3.2%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Wei Yu who wrote (3943)	7/9/1997 8:57:00 AM
From: Henry Niman	of 32384

wei, Actually, LGND's selection of stock is not only another indication that they are confident about future income, but it is also consistant with a move toward AHP. Last time they selected the stock form of payment from PFE, they also took advantage of an AHP line of credit which was paid for in LGND stock (to AHP). At that time they could have again accepted cash from PFE, but instead chose the stock. I have speculated on the movement toward AHP and the negative Phen Fen should have a negative impact on Redux sales and make LGND's obesity programs more attractive to AHP (who has a Redux distribution agreement with IPIC). Henry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next